| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | UTHR | Common Stock | Options Exercise | $721,560 | +6,000 | +16.39% | $120.26 | 42,599 | 16 Mar 2023 | Direct | F1, F2 |
| transaction | UTHR | Common Stock | Sale | -$100,636 | -475 | -1.12% | $211.87 | 42,124 | 16 Mar 2023 | Direct | F1, F3 |
| transaction | UTHR | Common Stock | Sale | -$272,783 | -1,277 | -3.03% | $213.61 | 40,847 | 16 Mar 2023 | Direct | F1, F4 |
| transaction | UTHR | Common Stock | Sale | -$541,007 | -2,522 | -6.17% | $214.52 | 38,325 | 16 Mar 2023 | Direct | F1, F5 |
| transaction | UTHR | Common Stock | Sale | -$328,697 | -1,526 | -3.98% | $215.4 | 36,799 | 16 Mar 2023 | Direct | F1, F6 |
| transaction | UTHR | Common Stock | Sale | -$43,217 | -200 | -0.54% | $216.09 | 36,599 | 16 Mar 2023 | Direct | F1, F7 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | UTHR | Stock Options | Options Exercise | $0 | -6,000 | -11.88% | $0 | 44,500 | 16 Mar 2023 | Common Stock | 6,000 | $120.26 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. |
| F2 | Includes 112 shares acquired on March 3, 2023, under the United Therapeutics Corporation Employee Stock Purchase Plan. |
| F3 | This transaction was executed in multiple trades at prices ranging from $211.80 to $212.255. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F4 | This transaction was executed in multiple trades at prices ranging from $212.98 to $213.88. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F5 | This transaction was executed in multiple trades at prices ranging from $214.00 to $214.99. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F6 | This transaction was executed in multiple trades at prices ranging from $215.02 to $215.695. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F7 | This transaction was executed in multiple trades at prices ranging from $216.06 to $216.09. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |